FDA Inspection 1286502 - Biocon Generics Inc. - October 10, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Biocon Generics Inc., with an inspection on October 10, 2025, issued by the New Jersey District Office, covering human drugs.

Company: Biocon Generics Inc.
Inspection Date: October 10, 2025
Product Type: Human Drugs
Office: New Jersey District Office

Open in Dashboard

ID · bff19b88-665e-45f3-8c69-560621c8beba

Violation Codes1

21 CFR 211.142

Full citation text and observation details available on the Dashboard.